Q1 2023 Holdings
Filed 2023-05-15 | 74 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Krystal Biotech Inc(KRYS) | Common Stocks | 501147102 | $15.7M | 195,980 | 1.4% |
| Axonics Inc(AXNX*) | Common Stocks | 05465P101 | $16.9M | 309,240 | 1.5% |
| Axogen Inc(AXGN) | Common Stocks | 05463X106 | $18.3M | 1,941,096 | 1.7% |
| Omnicell COM(OMCL) | Common Stocks | 68213N109 | $19.6M | 333,509 | 1.8% |
| Bellus Health Inc New(BLU) | Common Stocks | 07987C204 | $21.7M | 3,020,393 | 2.0% |
| Health Catalyst Inc(HCAT) | Common Stocks | 42225T107 | $23.1M | 1,980,317 | 2.1% |
| Tandem Diabetes Care Inc(TNDM) | Common Stocks | 875372203 | $23.9M | 589,185 | 2.2% |
| Keros Therapeutics Inc(KROS) | Common Stocks | 492327101 | $25.4M | 593,964 | 2.3% |
| Transmedics Group Inc(TMDX) | Common Stocks | 89377M109 | $25.6M | 337,912 | 2.3% |
| Crinetics Pharmaceuticals in(CRNX) | Common Stocks | 22663K107 | $26.0M | 1,619,125 | 2.3% |
| Koru Medical Systems Inc(KRMD) | Common Stocks | 759910102 | $26.1M | 6,191,317 | 2.4% |
| Halozyme Therapeutics Inc(HALO) | Common Stocks | 40637H109 | $26.3M | 688,206 | 2.4% |
| Performant Finl Corp(PFMTUSD) | Common Stocks | 71377E105 | $27.9M | 8,210,699 | 2.5% |
| Paragon 28 Inc(FNAUSD) | Common Stocks | 69913P105 | $34.8M | 2,037,939 | 3.1% |
| Pliant Therapeutics Inc(PLRX) | Common Stocks | 729139105 | $37.9M | 1,425,354 | 3.4% |
| Si-Bone Inc(SIBN) | Common Stocks | 825704109 | $41.6M | 2,114,212 | 3.7% |
| Karuna Therapeutics Inc | Common Stocks | 48576A100 | $44.3M | 243,675 | 4.0% |
| Orthofix MED Inc(OFIX) | Common Stocks | 68752M108 | $44.4M | 2,650,971 | 4.0% |
| Alphatec Hldgs Inc(ATEC) | Common Stocks | 02081G201 | $45.9M | 2,944,125 | 4.1% |
| Neogenomics Inc(NEO) | Common Stocks | 64049M209 | $47.0M | 2,698,958 | 4.2% |
| Atricure Inc(ATRC) | Common Stocks | 04963C209 | $60.5M | 1,459,057 | 5.4% |
| Model N Inc(MODNEUR) | Common Stocks | 607525102 | $62.0M | 1,853,673 | 5.6% |
| Prothena Corp PLC(PRTA) | Common Stocks | G72800108 | $73.2M | 1,511,168 | 6.6% |
| Reata Pharmaceuticals Inc(RETAEUR) | Common Stocks | 75615P103 | $144.3M | 1,586,928 | 13.0% |